Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Late-Breaking Clinical Science Structural I

LATE-BREAKING CLINICAL SCIENCE | STRUCTURAL I

Sunday, March 9, 2025
2:15 PM – 3:30 PM ET

    Late Breaker Moderator(s)

  • Samir R. Kapadia, MD, FSCAI

    Chairman, Cardiovascular Medicine
    Cleveland Clinic
    Cleveland, Ohio, United States

    Disclosure(s): No financial relationships to disclose

  • Ron Waksman, MD, MSCAI

    Director, Cardiovascular Research and Advanced Education
    MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
    Washington, District of Columbia, United States

    Disclosure information not submitted.

    • Panelist(s)

  • Gregory P. Fontana, MD

    Director, CardioVascular Institute
    Hospital Corporation of America
    Thousand oaks, United States

    Disclosure information not submitted.

  • Raj Makkar, MD, FSCAI, FACC

    Vice President of Cardiovascular Innovation and Intervention
    Cedars-Sinai Medical Center
    Los Angeles, California, United States

    Disclosure information not submitted.

  • Danny Dvir, MD

    MD
    SZMC, Israel

    Disclosure information not submitted.

  • Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

    Professor and Clinical Director of Interventional cardiology
    Thoraxcenter
    Rotterdam, Zuid-Holland, Netherlands

    Disclosure(s): Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Molly Szerlip, MD

    Associate Medical Director, Education & Reserach and Regional Director, Sturctural Heart Progam
    Baylor Scott and White The Heart Hospital Baylor Plano
    Richardson, Texas, United States

    Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisory Board (Ongoing); Cardiovascular Innovations Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Vinod Thourani, MD, FACC, FACS

    Professor of Surgery, Chairman of Cardiovascular Surgery
    Piedmont Heart Institute
    Atlanta, Georgia, United States

    Disclosure(s): Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); boston scientific: Grant/Research Support (Ongoing); Croivalve: Consultant (Ongoing), Grant/Research Support (Ongoing); DASI Simulations: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); Laplace: Grant/Research Support (Ongoing); medtronic.: Grant/Research Support (Ongoing); trisol: Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Santiago Garcia, MD

    Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
    The Christ Hospital
    Cincinnati, Ohio, United States

    Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

  • Bruce J. Rutkin, MD

    Director of Structural Heart Disease
    Northwell Health
    Manhasset, New York, United States

    Disclosure information not submitted.

  • Adam B. Greenbaum, FACC, FSCAI

    Co-director, Structural Heart and Valve Center
    Emory University
    Atlanta, Georgia, United States

    Disclosure information not submitted.